Close
Smartlab Europe
Inizio Ignite

Press Releases

Pistoia Alliance Launches New Community of Experts to Use Social Media Insights to Drive Patient-Centric Drug Development

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) to harness real-world data from social media. The COE aims to develop best practices and...

Malvern Panalytical and Applied Photophysics announce distribution agreement for Protein Stable’s SUPR-DSF

Malvern Panalytical (Malvern, UK) and Applied Photophysics (Leatherhead, UK) have announced their commercial agreement for Malvern Panalytical to distribute Protein Stable’s microplate-based differential scanning fluorimeter, SUPR-DSF, in the United States of America and Canada. The SUPR-DSF provides researchers with high-throughput...

Tjoapack strengthens its Injectables offering with addition of pre-filled syringes assembly and packaging service

Global pharmaceutical contract packaging organisation (CPO), Tjoapack has invested in a new high-speed packaging line for pre-filled syringes and vials at its production facilities in both Europe and the US. The recently validated PFS line can pack pre-filled syringes of...

Mural Health Enters the Market to Disrupt Clinical Trial Participant Management Through the Launch of Mural Link Platform

Mural Health Technologies, Inc., a new global provider of clinical trials technology, announced the launch of its new technology platform, Mural Link, which has been built to make it easy to be a participant in global clinical research studies....

Bimekizumab Demonstrated Sustained Clinical Responses to Week 52 in Phase 3 Studies in Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis

UCB, a global biopharmaceutical company, announced the first presentation of long-term, 52-week data from three Phase 3 studies evaluating the efficacy and safety of bimekizumab in adults with active psoriatic arthritis (PsA) who were biologic-naïve (BE OPTIMAL), in adults...

Clinerion launches its Federated Machine Learning Platform

Clinerion launches its Federated Machine Learning Platform, a global, federated machine learning (ML) platform on its Patient Network Explorer infrastructure, incorporating its global network of partner hospitals. This new platform will enable sophisticated analytics and pattern recognition use cases...

UCB Reinforces Commitment to Rheumatology with 15 Abstracts including New Late-Breaking Data at ACR Convergence 2022

UCB, a global biopharmaceutical company, announced that it will present 15 abstracts across its rheumatology portfolio at ACR Convergence 2022 to be held in Philadelphia, November 10–14, 2022. The abstracts, including two with late-breaking data, have been accepted as...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »